| Entry |
|
|---|
| Name |
Lucitanib (USAN/INN) |
|---|
| Formula |
C26H25N3O4
|
|---|
| Exact mass |
443.1845
|
|---|
| Mol weight |
443.4944
|
|---|
| Structure |
|
|---|
| Efficacy |
Antineoplastic, Receptor tyrosine kinase inhibitor |
|---|
| Comment |
Treatment of solid tumors
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Receptor tyrosine kinases (RTK)
FGFR family
FGFR1 (CD331)
D11762 Lucitanib (USAN/INN)
FGFR2 (CD332)
D11762 Lucitanib (USAN/INN)
VEGFR family
VEGFR1 (FLT1)
D11762 Lucitanib (USAN/INN)
VEGFR2 (KDR)
D11762 Lucitanib (USAN/INN)
VEGFR3 (FLT4)
D11762 Lucitanib (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 33
1 C8x C 21.2100 -19.6000
2 C8x C 21.2100 -18.2000
3 C8x C 20.0200 -17.5000
4 C8y C 18.7600 -18.2000
5 C8y C 18.7600 -19.6000
6 C8y C 20.0200 -20.3000
7 C8x C 17.5700 -17.5000
8 C8y C 16.3800 -18.2000
9 C8x C 16.3800 -19.6000
10 C8x C 17.5700 -20.3000
11 C5a C 20.0200 -21.7000
12 N1b N 21.2100 -22.4000
13 C1a C 22.4000 -21.7000
14 O5a O 18.8300 -22.4000
15 O2a O 15.1900 -17.5000
16 C8y C 15.1900 -16.1000
17 C8x C 16.3800 -15.4000
18 C8x C 16.3800 -14.0000
19 N5x N 15.1900 -13.3000
20 C8y C 13.9300 -14.0000
21 C8y C 13.9300 -15.4000
22 C8x C 12.7400 -13.3000
23 C8y C 11.5500 -14.0000
24 C8y C 11.5500 -15.4000
25 C8x C 12.7400 -16.1000
26 O2a O 10.3600 -13.3000
27 C1b C 9.1700 -14.0000
28 C1z C 7.9800 -13.3000
29 O2a O 10.3600 -16.1000
30 C1a C 9.1700 -15.4000
31 N1a N 6.7900 -14.0000
32 C1x C 8.6800 -12.1100
33 C1x C 7.2800 -12.1100
BOND 37
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 9 10 2
11 5 10 1
12 6 11 1
13 11 12 1
14 12 13 1
15 11 14 2
16 8 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 20 21 2
23 16 21 1
24 20 22 1
25 22 23 2
26 23 24 1
27 24 25 2
28 21 25 1
29 23 26 1
30 26 27 1
31 27 28 1
32 24 29 1
33 29 30 1
34 28 31 1
35 32 33 1
36 33 28 1
37 28 32 1
|
|---|
